Credit Suisse’s ContraFect Corporation CFRX Stock Holding History

Credit Suisse’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-625	Closed	-$132K	–	4563
2021 Q4	$132K	Buy	+625	New	+$172K	﹤0.01%	4354
2015 Q2	–	Sell	-109	Closed	-$450K	–	4695
2015 Q1	$450K	Buy	+109	New	+$396K	﹤0.01%	3615

Other funds holding CFRX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse's CFRX Position: Q1 2022 in Review

Credit Suisse sold out of ContraFect Corporation (CFRX) in Q1 2022, closing a stake of 625 shares — an estimated $132K sold.

Credit Suisse first reported a position in CFRX in Q1 2015 and held it in 2 quarters. The position peaked at $450K in Q1 2015. 52 funds tracked by Wall St. Rank hold CFRX as of Q1 2022.

Credit Suisse reported no remaining ContraFect Corporation position as of Q1 2022 after selling out during the quarter.
Credit Suisse sold 625 ContraFect Corporation shares in Q1 2022, an estimated $132K.
Credit Suisse first reported a position in ContraFect Corporation in Q1 2015 and held it in 2 quarters.
Credit Suisse's ContraFect Corporation position peaked at $450K in Q1 2015.
52 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2022.

Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.